JAKARTA/HANOI -- Vaccine diplomacy by China and the U.S. has entered a new stage as their drugmakers transfer technology to players in Southeast Asia to kick-start local production.
The region has welcomed these efforts, since it provides a greater boost to the pharmaceutical industry there and creates more jobs than shipments of ready-for-use coronavirus jabs. Some companies have even begun testing vaccines in Southeast Asia that have yet to receive authorization in the countries in which they were produced.
